GNBT News and Press, Generex Biotechnology From 09/10/19

Generex Biotechnology ( OTCQB:GNBT ) has signed letters of intent with Arizona Endocrinology Center and Paradise Valley Family Medicine to establish NuGenerex Health, LLC, a management services organization (MSO) focused on the delivery and management of healthcare services for patients wi...

MIRAMAR, Fla., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB:GNBT) announces that the Company has signed letters of intent with Arizona Endocrinology Center and Paradise Valley Family Medicine to establish NuGenerex Health, LLC, a management services organizati...

Generex Biotechnology ( OTCQB:GNBT +10.6% ) inks a binding letter of intent to acquire 51% of privately held ALTuCELL  for an undisclosed sum of cash and stock. More news on: Generex Biotechnology Corporation, Healthcare stocks news, Stocks on the move, Merger & acquisition n...

Patented cell encapsulation technology enables cell implantation for therapeutic and regenerative medicine application without immune system rejection Microcapsules formulated with ultra-purified alginates and poly-L-ornithine previously have previously received authorization from the EME...

Annual Meeting Scheduled for October 25, 2019 Retiring Pool shares reduces outstanding shares from 63,793,955 shares to 43,418,055 shares, a 31.9% reduction in outstanding shares MIRAMAR, Fla., Sept. 06, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OT...

CEO Joe Moscato’s Presentation at the  H.C. Wainwright 21 st  ANNUAL GLOBAL INVESTMENT CONFERENCE to be Webcast by Wall Street Webcasting Monday September 9, 2019 3:25 PM MIRAMAR, Fla., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB:...

Record date of August 30, 2019 confirmed Shareholders must hold shares through October 30, 2019 to receive dividend Dividend Waived by insiders, note holders, acquisitions, and pool shares Pool shares being retired on October 30, 2019 MIRAMAR, Fla., Sept. 03, 2019 (GLOBE NEWSWIRE) -...

H.C. WAINWRIGHT 21 st ANNUAL GLOBAL INVESTMENT CONFERENCE The Lotte New York Palace Hotel, New York, NY September 8 – 10, 2019 Mon, Sep 9  at  3:25 - 3:50 PM  in Holmes II (4th Floor) MIRAMAR, Fla., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corpor...

Filing of up-list application to Nasdaq Record date for dividend is August 30, 2019 Pay date for 1:1 shareholder stock dividend set for October 29, 2019 Ex-dividend date for 1:1 shareholder stock dividend set for October 30, 2019 Effect of Dividend on GNBT Shares Outstanding -- Retiri...

Generex  Now Owns 99% of Subsidiary Olaregen Therapeutix Generex Satisfies Notes for $138,000 and $900,000 to clear debt NuGenerex Immuno-Oncology Spin-out Evaluating Acquisition of a Hospital Network Completed Audit of Direct-to-Patient Pharmacy Business MIRAMAR, Fla., Aug. 1...